About the Choriocarcinoma Session
Choriocarcinoma, a rare but aggressive form of cancer, poses significant challenges in cancer research. Originating from abnormal placental tissue, it can occur after molar pregnancies or even during normal pregnancies. Despite its rarity, its rapid growth and propensity to metastasize demand urgent attention. Researchers focus on understanding its underlying genetic mutations and signaling pathways to develop targeted therapies. Additionally, advancements in imaging techniques aid in early detection and monitoring of the disease progression. Collaborative efforts among oncologists, geneticists, and reproductive specialists are crucial for improving treatment outcomes and fertility preservation options for affected individuals. Through interdisciplinary research endeavors, the quest to unravel the mysteries of choriocarcinoma continues, offering hope for more effective interventions and better prognoses in the future.
Topics Covered in Choriocarcinoma
Trophoblastic Neoplasia
Molar Pregnancy
Gonadotropin Monitoring
Prognostic Risk Scoring
Multiagent Chemotherapy
Non-Gestational Forms
Related Scientific Sessions at CIOC 2027
Why Attend the Choriocarcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Choriocarcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Choriocarcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Choriocarcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Choriocarcinoma Conference 2027 — FAQs
What is the Choriocarcinoma track at CIOC 2027?
The Choriocarcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Choriocarcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Choriocarcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Choriocarcinoma are all welcome — whether presenting or attending.
Can I present my research in the Choriocarcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Choriocarcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Choriocarcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.